Interactions of nonpeptide angiotensin II receptor antagonists at imidazoline/guanidinium receptor sites in rat forebrain

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 3, 1996, Pages 425-431

  Li, Zhongyu ^a   Bosch, Susan M ^a   Smith, Thomas L ^a   Diz, Debra I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Arcuate nucleus; AT1 and AT2 antagonists; Imidazoline guanidinium receptive sites; Nonpeptide angiotensin II receptor antagonists; Subfornical organ

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CANDESARTAN; CIRAZOLINE; CLONIDINE; GUANIDINE; IDAZOXAN; IMIDAZOLINE DERIVATIVE; IMIDAZOLINE RECEPTOR; LOSARTAN POTASSIUM; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CARDIOVASCULAR FUNCTION; DOSE RESPONSE; DRUG RECEPTOR BINDING; FEMALE; FOREBRAIN; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBFORNICAL ORGAN;

ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; AUTORADIOGRAPHY; BIPHENYL COMPOUNDS; IMIDAZOLES; LOSARTAN; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANGIOTENSIN; TETRAZOLES;

EID: 0029841638     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199609000-00012     Document Type: Article

References (36)

1. Parini A, Coupry I, Graham RM, Uzielli I, Atlas D, Lanier S. Characterization of an imidazoline/guanidinium receptive site distinct from the a-2 adrenergic receptor. J Biol Chem 1989;264:11874-8.
2. Reis DJ, Li G, Regunathan S. Endogenous ligands of imidazoline receptors: classic and immunoreactive clonidine-displacing substance and agmatine. Ann NY Acad Sci 1995; 763:295-313.
3. Regunathan S, Youngson C, Wang H, Reis DJ. Imidazoline receptors in vascular smooth muscle and endothelial cells. Ann NY Acad Sci 1995;763:580-90.
4. Ivkovic B, Bakthavachalam V, Zhang W, et al. Development of a high-affinity radioiodinated ligand for identification of imidazoline/guanidinium receptor sites (IGRS): intratissue distribution of IGRS in liver, forebrain, and kidney. Mol Pharmacol 1994;46:15-23.
5. Johnson AK, Gross PM. Sensory circumventricular organs and brain homeostatic pathways. FASEB J 1993;7:678-86.
6. Bains JS, Ferguson AV. Paraventricular nucleus neurons projecting to the spinal cord receive excitatory input from the subfornical organ. Am J Physiol 1995;268:R625-33.
7. Brody MJ, O'Neill TP, Porter JP. Role of paraventricular and arcuate nuclei in cardiovascular regulation. In: Margo A, Osswald W, Reis D, Vanhoutte P, eds. Central and peripheral mechanism of cardiovascular regulation. New York: Plenum, 1986;443-64.
8. Chiu AT, Herblin WF, McCall DE, et al. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989;165:196-203.
9. Chiu AT, McCall DE, Price WA, et al. Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther 1990;252:711-8.
10. Wong PC, Price WA, Jr., Chiu AT, et al. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther 1990;255: 211-7.
11. Wong PC, Price WA, Chiu AT, et al. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther 1990;252:726-32.
12. Basso N, Kurnjek ML, Ruiz P, Cannata MA. Effect of EXP3174 on blood pressure of normoreninemic renal hypertensive rats. Hypertension 1994;25:283-7.
13. Timmermans PB, Carini DJ, Chiu AT, et al. The discovery of a new class of highly specific nonpeptide angiotensin II receptor antagonists. Am J Hypertens 1991;4:275S-81S.
14. Rhaleb NE, Rouissi N, Nantel F, D'Orleans-Juste P, Regoli D. DuP 753 is a specific antagonist for the angiotensin receptor. Hypertension 1991;17:480-4.
15. Liu ECK, Hedberg A, Goldenberg HJ, Harris DN, Webb ML. DuP 753, the selective angiotensin II receptor blocker, is a competitive antagonist to human platelet thromboxane A2/prostaglandin H2 (TP) receptors. Prostaglandins 1992;44:89-99.
16. Bertolino F, Vanentin JP, Maffre M, Jover B, Bessac AM, John GW. Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin 11 type 1. J Pharmacol Exp Ther 1993:268:747-68.
17. Chretien L, Guillemette G, Regoli D. Non-peptide receptor antagonists bind to tachykinin NK3 receptors of rat and guinea pig brain. Eur J Pharmacol 1994;256:73-8.
18. Picard P, Chretien L, Couture R. Functional interaction between losartan and central tachykinin NK3 receptors in the conscious rat. Br J Pharmacol 1995;114:1563-70.
19. Ishizaki H, Ohtawa M. Inhibitory effect of the nonpeptide angiotensin II receptor antagonist losartan and its active metabolite, E-3174, on cAMP phosphodiesterase: additional action of the antagonists, Biochem Pharmacol 1994;48:201-4.
20. Tsutsumi K, Saavedra M. Quantitative autoradiography reveals different angiotensin II receptor subtypes in selected rat brain nuclei. J Neurochem 1991;56:348-51.
21. Goldfarb DA, Diz DI, Tubbs RR, Ferrario CM, Novick AC. Angiotensin II receptor subtypes in the human renal cortex and renal cell carcinoma. J Urol 1994;151:206-13.
22. Chappell MC, Diz DI, Jacobsen DW. Pharmacological characterization of angiotensin II binding sites in the canine pancreas. Peptides 1992;13:313-8.
23. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Australia: Academic Press, 1996:plate 23-28.
24. Hogarty DC, Speakman EA, Puig V, Phillips MI. The role of angiotensin, AT1 and AT2 receptors in the pressor: drinking and vasopressin responses to central angiotensin. Brain Res 1992;586:289-94.
25. Widdop RE, Gardiner SM, Kemp PA, Bennett T. Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the AT1-receptor antagonist, EXP 3174. Br J Pharmacol 1992;107: 873-80.
26. Saavedra JM, Correa FM, Kurihara M, Shigematsu K. Increased number of angiotensin U receptors in the subfornical organ of spontaneously hypertensive rats. J Hypertens 1986; 4:S27-30.
27. Nazarali AJ, Gutkind JS, Correa FM, Saavedra JM. Decreased angiotensin 11 receptors in the subfornical organ of spontaneously hypertensive rats after chronic antihypertensive treatment with enalapril. Am J Hypertens 1995;3:59-61.
28. Ohlstein EH, Gellai M, Brooks DP, et al. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism. J Pharmacol Exp Ther 1992;262:595-601.
29. Jaiswal N, Diz DI, Tallant EA, Khosla MC, Ferrario CM. The non-peptide angiotensin II antagonist DuP 753 is a potent stimulus for prostacyclin release. Am J Hypertens 1991; 4:228-33.
30. Chansel D, Bizet T, Vandermeersch S, Pham P, Levy B, Ardaillou R. Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesengial cells. Am J Physiol (Renal Fluid Electrolyte Physiol) 1994;266:F384-93.
31. Chansel D, Vandermeersch S, Pham P, Ardaillou R. Characterization of (3H)losartan receptors in isolated rat glomeruli. Eur J Pharmacol Mol Pharmacol 1993;247:193-8.
32. Mallard NJ, Hudson AL, Nutt DH. Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain. Br J Pharmacol 1992; 106:1019-27.
33. Ernsberger P, Meeley MP, Mann JJ, Reis DJ. Clonidine binds to imidazoline sites as well as a2adrenoceptors in the ventrolateral medulla. Eur J Pharmacol 1987;134:1-13.
34. Ernsberger P, Giuliano R, Willette RN, Granata AR, Reis DJ. Hypotensive action of clonidine analogues correlates with binding affinity at imidazole and not a2-adrenergic receptors in the rostral ventrolateral medulla, J Hypertens 1988;6:554-7.
35. Lanier B, Raddatz R, Bakthavachalam V, Coupry I, Neumeyer JL, Lanier SM. Structural and ligand recognition properties of imidazoline binding proteins in tissues of rat and rabbit. Mot Pharmacol 1995;48:703-10.
36. Raddatz R, Parini A, Lanier SM. Imidazoline/guanidinium binding domains on monoamine oxidases. J Biol Chem 1995; 270:27961-8.